ATE138073T1 - 4-amino-delta4,6-steroide und ihre verwendung als inhibitoren von 5alpha-reduktase - Google Patents

4-amino-delta4,6-steroide und ihre verwendung als inhibitoren von 5alpha-reduktase

Info

Publication number
ATE138073T1
ATE138073T1 AT91112795T AT91112795T ATE138073T1 AT E138073 T1 ATE138073 T1 AT E138073T1 AT 91112795 T AT91112795 T AT 91112795T AT 91112795 T AT91112795 T AT 91112795T AT E138073 T1 ATE138073 T1 AT E138073T1
Authority
AT
Austria
Prior art keywords
steroids
reductase
inhibitors
amino
delta4
Prior art date
Application number
AT91112795T
Other languages
English (en)
Inventor
Philip M Weintraub
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/671,555 external-priority patent/US5143909A/en
Priority claimed from US07/720,899 external-priority patent/US5130424A/en
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE138073T1 publication Critical patent/ATE138073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91112795T 1990-08-01 1991-07-30 4-amino-delta4,6-steroide und ihre verwendung als inhibitoren von 5alpha-reduktase ATE138073T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56141090A 1990-08-01 1990-08-01
US07/671,555 US5143909A (en) 1991-03-19 1991-03-19 Aminosteroids in a method for inhibiting c17-20 lyase
US07/720,899 US5130424A (en) 1990-08-01 1991-07-02 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors

Publications (1)

Publication Number Publication Date
ATE138073T1 true ATE138073T1 (de) 1996-06-15

Family

ID=27415853

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91112795T ATE138073T1 (de) 1990-08-01 1991-07-30 4-amino-delta4,6-steroide und ihre verwendung als inhibitoren von 5alpha-reduktase

Country Status (17)

Country Link
EP (1) EP0469547B1 (de)
JP (1) JP3021818B2 (de)
CN (1) CN1031574C (de)
AT (1) ATE138073T1 (de)
AU (1) AU642757B2 (de)
CA (1) CA2048243C (de)
DE (1) DE69119502T2 (de)
DK (1) DK0469547T3 (de)
ES (1) ES2089063T3 (de)
FI (1) FI102378B (de)
GR (1) GR3020268T3 (de)
HU (1) HU210042B (de)
IE (1) IE75199B1 (de)
IL (1) IL98998A (de)
NO (1) NO180197C (de)
NZ (1) NZ239141A (de)
PT (1) PT98519B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543406A (en) * 1991-12-20 1996-08-06 Glaxo Wellcome, Inc. Inhibitors of 5-α-testosterone reductase
US5302589A (en) * 1992-08-07 1994-04-12 Glaxo, Inc. Heterocyclic inhibitors of 5-α-testosterone reductase
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5356935A (en) * 1993-12-13 1994-10-18 Eli Lilly And Company Reduced phenanthrenes
AU686793B2 (en) * 1994-05-02 1998-02-12 Merrell Pharmaceuticals Inc. Process for the preparation of 4-amino- 4-3-ketosteroids via 4-nitro-delta 4-3-ketosteroids
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
WO2001005364A1 (en) * 1999-07-15 2001-01-25 The Procter & Gamble Company Nitrogen-containing steroid compounds and their use to regulate hair growth
JP6353939B1 (ja) * 2017-02-15 2018-07-04 横関油脂工業株式会社 油状組成物、その製法、油性基剤および皮膚外用剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1154008A (en) * 1979-05-02 1983-09-20 Thomas R. Blohm STEROID 5.alpha.-REDUCTASE INHIBITORS
GB8503940D0 (en) * 1985-02-15 1985-03-20 Erba Farmitalia 4-substituted androstendione derivatives

Also Published As

Publication number Publication date
EP0469547A2 (de) 1992-02-05
FI102378B1 (fi) 1998-11-30
NZ239141A (en) 1994-04-27
HUT59157A (en) 1992-04-28
FI913658A0 (fi) 1991-07-31
DE69119502D1 (de) 1996-06-20
IE912706A1 (en) 1992-02-12
FI913658L (fi) 1992-02-02
JPH05320189A (ja) 1993-12-03
AU642757B2 (en) 1993-10-28
PT98519B (pt) 1999-01-29
NO180197B (no) 1996-11-25
EP0469547A3 (en) 1992-06-03
AU8135691A (en) 1992-02-06
CA2048243C (en) 2003-04-08
CA2048243A1 (en) 1992-02-02
JP3021818B2 (ja) 2000-03-15
IL98998A (en) 1996-01-19
FI102378B (fi) 1998-11-30
HU912559D0 (en) 1992-01-28
NO912982L (no) 1992-02-03
ES2089063T3 (es) 1996-10-01
CN1031574C (zh) 1996-04-17
IE75199B1 (en) 1997-08-27
NO912982D0 (no) 1991-07-31
CN1059150A (zh) 1992-03-04
PT98519A (pt) 1992-06-30
GR3020268T3 (en) 1996-09-30
DE69119502T2 (de) 1996-09-26
DK0469547T3 (da) 1996-06-10
NO180197C (no) 1997-03-05
EP0469547B1 (de) 1996-05-15
IL98998A0 (en) 1992-07-15
HU210042B (en) 1995-01-30

Similar Documents

Publication Publication Date Title
ATE69239T1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
DE69119502D1 (de) 4-Amino-delta4,6-Steroide und ihre Verwendung als Inhibitoren von 5alpha-Reduktase
ATE181056T1 (de) Arylessigsäurederivate und ihre verwendung als fungizide
ATE209187T1 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
KR930023353A (ko) 1-(3-할로-4-트리플루오로메틸페닐)테트라졸리논 유도체
ATE138931T1 (de) 4-amino-delta4-steroide und ihre verwendung als inhibitoren von 5alpha-reduktase
GB1328732A (en) Substituted phenylhydrazones processes for their preparation and compositions incorporating them
ATE55603T1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
FI872980A0 (fi) Isokinolinfoereningar, vilka har en kvaevesubstituent i 4-positionen och vilka har kardiotona fosfodiesterasfraktion iii-inhiberade egenskaper och/eller njurvasodilatoriska egenskaper.
ATE19626T1 (de) Substituierte hydroxyalkyl-azole, verfahren zu ihrer herstellung und ihre verwendung als antimykotika.
D'Amico et al. Derivatives of 4-chloro-3, 5-dinitrobenzotrifluoride. 2. Synthesis of 2-(trifluoromethyl)-4-nitrobenzimidazo [2, 1-b] benzothiazole and related compounds
JPS5585551A (en) New tricycloundecane amino acid amide
KR840001176A (ko) 이미다조퀴나졸린 유도체의 제조방법
DK0662475T3 (da) Fremgangsmåde til fremstilling af 2-perfluoralkyl-3-oxazolin-5-on.
HUT39445A (en) Herbicides containing as reagent derivatives of benzodisultam and process for production of the reagents
IE41394L (en) Benzimidazole derivatives
KR870003059A (ko) 3개의 벤젠 고리가 아마이드 결합으로 연결된 디카르복실산 유도체의 제조 방법
ATE46145T1 (de) Verfahren zur herstellung von 2-isocyanato-2,3dehydrocarbon-saeureestern.
KR970006299A (ko) 란소프라졸의 제조방법
DE3576076D1 (de) (tetrazolyl)thienopyridone.
KR970061899A (ko) 3-할로메틸-3-세펨-4-카르복실레이트 1-옥사이드의 신규 제조방법
KR930010012A (ko) 4,5-디클로로-2-n-옥틸-4-이소티아졸린-3-온의 제조방법
SE8405002D0 (sv) Framstellning av bensotiazindioxid
KR900003149A (ko) 신규한 퀴놀론 카복실산 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee